Project Overview 

Predicting patient response to therapy remains a major challenge in drug development and clinical research. Transcriptomics and other high-throughput omics data enable more accurate response prediction, supporting data-driven decision-making in the clinic, pharma, and biotech.

Services Provided

• Development of predictive models using patient transcriptomics/omics data.
• Provide interpretable model outputs highlighting key genes, pathways, or molecular features driving predicted patient outcomes.
• Validation of model predictions against clinical outcomes or publicly available experimental datasets.

Deliverables & Benefits

• Stratification of patients into predicted responders and non-responders.
• Prioritization of treatments based on predicted cellular or patient responses.

Why Choose Lucid Analytics? 

With a deep understanding of life sciences and cutting-edge AI expertise, Lucid Analytics supports clients in accelerating innovation and driving impactful R&D outcomes.

Ready to Transform Your Data? 

Interested in how we can help with your next project? Contact us today to explore how data can drive your R&D success.